The certification does not trigger any immediate cuts for the 3,200-student school system, which is struggling with how to ...

I wonder whether the complexity of Blue Owl’s structure, the inherent opacity of publicly traded private credit and stress to ...

Q1 2026 Earnings Call December 10, 2025 11:00 AM ESTCompany ParticipantsAmir Adnani - President, CEO & DirectorBrent Berg ...

Clinicians Laura Huppert, Kelsey Natsuhara, and Magdelena Ford discuss the evidence, challenges, and real-world ...

Long the titan of prep schools in Los Angeles, with a reputation as an Ivy League feeder, Harvard-Westlake has seen the ...

MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS ...

Horse racing betting expert Sam Turner returns with the fourth edition of his exclusive Cheltenham Festival countdown column and singles out a Sandown performance to note ...

With longer trial follow-up, 79% response seen in disease resistant to therapy ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that three studies of its novel BCL2 ...

Securitised assets in the US offer diversification benefits in a marketplace that, following post-financial crisis regulation ...

The Royalty consists of a 25% NSR on gold and a 2% NSR on copper and other products produced from the Pedra Branca mine, comprising the Pedra Branca West and Pedra Branca East areas, and the former ...

Terns Pharmaceuticals, Inc. ( TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia December 8, 2025 4:30 PM EST ...